SB 5921 Washington Senate · 2025-2026 Regular Session

Concerning psilocybin.

Washington State's SB 5921 establishes a legal medical program for psilocybin use under the Department of Health, allowing licensed clinicians to prescribe it for qualified patients (18+ years) with diagnosed conditions determined by the clinician. The bill creates clear rules for inpatient treatment sessions, outpatient microdosing, and strict requirements for producers (growers/manufacturers) and clinicians. It provides legal protections from prosecution for program participants but maintains existing laws for non-program activities like driving under influence or recreational use. The program explicitly excludes use for individuals under 18, animals, and does not override federal laws governing clinical trials.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2025
Committee Review
Floor Vote
Governor
Introduced Dec 19, 2025 Last action Feb 4, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
9
Key actions
5
Committee
7
Feb 4, 2026
Committee
Referred to Ways & Means.
upper
Feb 3, 2026
Upper · Passed
Minority; without recommendation.
upper
Feb 3, 2026
Upper · Passed
Minority; do not pass.
upper
Feb 3, 2026
Committee
And refer to Ways & Means.
upper
Feb 3, 2026
Upper · Passed
HLTC - Majority; do pass.
upper
Feb 3, 2026
Upper · Passed
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM.
upper
Jan 27, 2026
Upper · Passed
Public hearing in the Senate Committee on Health & Long-Term Care at 10:30 AM.
upper
1 primary · 6 co-sponsors

Sponsors